End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,784 MXN | -0.89% |
|
+0.39% | +69.81% |
Jul. 16 | Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly | MT |
Jul. 16 | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- LLY Stock
- LLY * Stock
- Charts Eli Lilly and Company